Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03584009
Brief Title: A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

First Submitted : June 25, 2018
First Submitted that Met QC Criteria : July 10, 2018
First Posted : July 12, 2018

Last Update Submitted that Met QC Criteria : November 6, 2019
Last Update Posted : November 7, 2019